After BZ or BAY-11 treatment, NF-κB DNA-binding activity (Fig. 6A) and the level of phosphorylated-IκBɑ (Fig. 6B) gradually declined in a dose-dependent manner in the MS DLBCL cell line. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.